Physician profile
Anda Neagoe
NPI 1265093439
$523.53
in general payments reported to CMS, 2019-2025
9 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.57 · 2023: $141 · 2024: $93.53 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $195.23 | 2023-2025 | Ozempic, Rybelsus |
| Organon LLC | $85.57 | 2022 | |
| Lilly USA, LLC | $62.17 | 2024-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $48.16 | 2024-2025 | Shingrix |
| Pfizer INC. | $37.64 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $28.55 | 2025 | Airsupra |
| Hologic Sales and Service, LLC | $24.93 | 2024 | Aptima |
| Baxter Healthcare | $23.14 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $18.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anda Neagoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.